Macquarie says these 3 ASX 200 stocks can return 38% to 93%

Three very different companies which could deliver outsized returns.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Reporting season is starting to kick off, and as it does, the brokers have more to work with in order to assess the value of companies on their radar.

I've selected three new reports from Macquarie out this week, which identify stocks they think are undervalued at current levels.

Let's see who they like.

A woman in a red dress holding up a red graph.

Image source: Getty Images

Pinnacle Investment Management Ltd (ASX: PNI)  

Pinnacle this week reported a net profit of $176.7 million, up 31% on the previous financial year, or $138 million, up 21%, if subtracting the impact of the company's acquisition of PAM.

The company declared a final dividend of 31 cents, bringing total dividends for the year to 60 cents, in line with FY25, and reported net inflows of funds under management of $33.4 billion for the year.

Pinnacle Managing Director Ian Macoun said:

We continue to build Pinnacle to deliver sustained high rates of growth for many years into the future. Our distinct business model and Three Horizons growth strategy have built a highly diversified platform across asset classes, geographies and product formats. This platform has supported strong growth to date and provides multiple pathways for further growth, including in larger international markets where we have demonstrated that the Pinnacle model can operate successfully.

Macquarie has an outperform rating on the stock, citing attractive organic growth and potential accretive M&A.

The broker has a price target of $23.95 for the stock, compared with $19.53 currently.

Pexa Ltd (ASX: PXA)

Pexa shares are down 52.3% over the past 12 months, begging the question: Is it time for a recovery?

Macquarie has done an analysis ahead of the property settlement technology company's results, and said that settlement activity in New South Wales was down sharply in July, falling 11.6% compared to the same month in 2025.

Macquarie is still forecasting that more Tier-1 lenders will take up the use of the platform however, and have left their share price target for Pexa unchanged at $14.85, compared to $7.66 currently.

Pexa is scheduled to report its full-year results on 28 August.

Light & Wonder Inc (ASX: LNW)

Light & Wonder shares are also down over the past 12 months, losing 12.8% in value.

The company recently reported that net profit had increased 26% to US$120 million, with revenue up 2% to US$828 million.

The company said:

We continue to enhance our quality of earnings through a deliberate strategy to improve revenue quality, focusing on growing recurring revenue. Gaming operations, Grover and iGaming represented the primary growth drivers, each delivering double-digit year-over-year revenue increases, supported by continued operational momentum and content strength.

Macquarie reduced its price target from $200 to $180 on the back of the results, but this is still well above the current level of $118.98.

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Light & Wonder Inc, Macquarie Group, and Pinnacle Investment Management Group. The Motley Fool Australia has positions in and has recommended Pinnacle Investment Management Group. The Motley Fool Australia has recommended Light & Wonder Inc and Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Plane taking off from Sydney airport with CBD in background.
Broker Notes

Buy, hold, sell: Macquarie, Fortescue, Qantas shares

We review 3 fresh buy, hold, and sell calls from expert market analysts. 

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Broker says this ASX 200 stock could rocket 50%+ in 12 months

Bell Potter has good things to say about this stock.

Read more »

Broker Notes

2 ASX 200 stocks drawing fresh buy ratings this week 

These shares have solid upside.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »